Vella_2008_Clin.Endocrinol.(Oxf)_69_737

Reference

Title : The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study - Vella_2008_Clin.Endocrinol.(Oxf)_69_737
Author(s) : Vella A , Bock G , Giesler PD , Burton DB , Serra DB , Saylan ML , Deacon CF , Foley JE , Rizza RA , Camilleri M
Ref : Clinical Endocrinology (Oxf) , 69 :737 , 2008
Abstract : Vella_2008_Clin.Endocrinol.(Oxf)_69_737
ESTHER : Vella_2008_Clin.Endocrinol.(Oxf)_69_737
PubMedSearch : Vella_2008_Clin.Endocrinol.(Oxf)_69_737
PubMedID: 18331607

Related information

Citations formats

Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M (2008)
The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study
Clinical Endocrinology (Oxf) 69 :737

Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M (2008)
Clinical Endocrinology (Oxf) 69 :737